PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Paz-Ares, L. G.
De Marinis, F.
Dediu, M.
Thomas, M.
Pujol, J.
Bidoli, P.
Molinier, O.
Sahoo, T. P.
Laack, E.
Reck, M.
Corral, J.
Melemed, S. A.
John, W. J.
Chouaki, N.
Zimmerman, A.
Grul, C. M. Visseren
Gridelli, C.
机构：
[1] Hosp Univ Virgen del Rocio, Seville, Spain
[2] San Camillo Forlanini Hosp, Rome, Italy
[3] Inst Oncol, Dept Med Oncol, Bucharest, Romania
[4] Heidelberg Univ, Thoraxklin, Heidelberg, Germany
[5] Montpellier Univ Hosp, Montpellier, France
[6] Az Osped S Gerardo, Monza, Italy
[7] Le Mans Reg Hosp, Le Mans, France
[8] Jawaharlal Nehru Canc Hosp & Res Ctr, Bhopal, India
[9] Ambulantes Krebszentrum Hamburg, Hamburg, Germany
[10] Hosp Grosshansdorf, Grosshansdorf, Germany
[11] Eli Lilly & Co, Indianapolis, IN 46285 USA
[12] Lilly France, Paris, France
[13] Lilly Oncol Europe, Houten, Netherlands
[14] SG Moscati Hosp, Avellino, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CRA7510
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melem, S. A.
    Grul, C. M. Visseren
    Gridelli, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [2] MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC AFTER PEM PLUS CISPLATIN FOR ADVANCED NONSQUAMOUS NSCLC
    Obasaju, C. K.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J. L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A.
    Visseren-Grul, C. M.
    Gridelli, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 8 - 8
  • [3] Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)
    Laack, E.
    Reck, M.
    Schumann, C.
    Eschbach, C.
    Kimmich, M.
    Brandts, C.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Pujol, J.-L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A. H.
    Visseren-Grul, C. M.
    Leschinger, M., I
    Thomas, M.
    [J]. ONKOLOGIE, 2012, 35 : 36 - 37
  • [4] PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis
    De Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Oliver
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Jaime, Jesus Corral
    Melemed, Symantha
    John, William J.
    Chouaki, Nadia
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Brodowicz, T.
    Ciuleanu, T.
    Kim, J. H.
    Krzakowski, M.
    Laack, E.
    Wu, Y. L.
    Peterson, P.
    Krejcy, K.
    Zielinski, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [6] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Brodowicz, T.
    Ciuleanu, T.
    Kim, J. H.
    Krzakowski, M.
    Laack, E.
    Wu, Y. L.
    Peterson, P.
    Krejcy, K.
    Zielinski, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] UPDATED SAFETY AND QUALITY OF LIFE (QOL) RESULTS OF PARAMOUNT STUDY: MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VS PLACEBO (PBO) PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEM PLUS CISPLATIN (CP) FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC)
    Pujol, J.
    Paz-Ares, L.
    Dediu, M.
    Thomas, M.
    Bidoli, P.
    Corral, J.
    Chouaki, N.
    Visseren-Grul, C. M.
    Zimmermann, A.
    Gridelli, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 418 - 419
  • [8] A RANDOMIZED PHASE 2 STUDY COMPARING MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS BSC ALONE FOLLOWING INDUCTION TREATMENT WITH PEM-CISPLATIN (CIS) IN ADVANCED NONSQUAMOUS (NONSQ) NON-SMALL CELL LUNG CANCER (NSCLC)
    Meshref, Mohamed
    Gaafar, Rabab M.
    Shehata, Samir
    Hashem, Tarek
    Gerges, Dani Abi
    Azim, Hamdy Abdel
    El-Husseiny, Gamal
    Al-Hussein, Hamed
    Liu, Zhixin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1263 - S1263
  • [9] SAFETY, RESOURCE USE, AND QUALITY OF LIFE (QOL) RESULTS FROM PARAMOUNT: A PHASE III STUDY OF MAINTENANCE PEMETREXED PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEMETREXED-CISPLATIN FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Gridelli, Cesare
    De Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Middleton, Gary
    Winfree, Katherine
    Melemed, Symantha
    Zimmermann, Annamaria H.
    John, William
    Beyrer, Julie
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz Ares, Luis
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S323 - S324
  • [10] Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study
    Ciuleanu, T. E.
    Brodowicz, T.
    Belani, C. P.
    Kim, J.
    Krzakowski, M.
    Laack, E.
    Wu, Y.
    Peterson, P.
    Adachi, S.
    Zielinski, C. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345